IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Accretion Pharmaceuticals IPO listing price is [●], issue price is ₹ 101.00, and currently trading at [●] as on [●]. Accretion Pharmaceuticals IPO performance is show below with lates CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Accretion Pharmaceuticals IPO is a Book Building listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Jawa Capital Services is the merchant banker of Accretion Pharmaceuticals IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 8th January 2025.
Accretion Pharmaceuticals IPO offer price is [●] and got listed at [●]. Read Accretion Pharmaceuticals IPO details mentioned above.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
₹ 101.00
Listing Price :
[●]
Previous Day Closing
[●]
Accretion Pharmaceuticals IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on manufactures and sells tablets, capsules, and other healthcare products.. The company is launching its SME UPCOMING IPO on the NSE EMERGE exchange, using the Book Building Issue method. Accretion Pharmaceuticals IPO size is ₹ 29.75 Cr. Crores with fresh issue size of Rs 29.75 Cr. Crores and Offer for sale being Nil.
The IPO allotment date for Accretion Pharmaceuticals IPO is expected to be 19th May 2025, after the finalization of basis of allotment. Investors can check Accretion Pharmaceuticals IPO allotment status on the registrars website, KFin Technologies Limited. Accretion Pharmaceuticals IPO refund dates are 20th May 2025.
Accretion Pharmaceuticals IPO is expected to be listed on 21st May 2025.
The upper price band for the Accretion Pharmaceuticals IPO is set at ₹ 101.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Accretion Pharmaceuticals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Accretion Pharmaceuticals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 16th May 2025. After submission, funds are blocked until the basis of allotment of Accretion Pharmaceuticals IPO is finalised.
The merchant banker for Accretion Pharmaceuticals IPO is Jawa Capital Services Private Limited . Jawa Capital Services Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Accretion Pharmaceuticals IPO RHP for further details.
The registrar for Accretion Pharmaceuticals IPO is KFin Technologies Limited. Investors can go to KFin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Accretion Pharmaceuticals IPO through their official website or helpline.
Accretion Pharmaceuticals IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Accretion Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Accretion Pharmaceuticals Financial Review Page
Merchant Banker(s) of Accretion Pharmaceuticals IPO: Jawa Capital Services Private Limited
Accretion Pharmaceuticals IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Accretion Pharmaceuticals IPO listed at a listing price of against the offer price of .
The current market price of Accretion Pharmaceuticals is .
Why Us?
